Literature DB >> 16611997

Essential dosage-dependent functions of the transcription factor yin yang 1 in late embryonic development and cell cycle progression.

El Bachir Affar1, Frédérique Gay, Yujiang Shi, Huifei Liu, Maite Huarte, Su Wu, Tucker Collins, En Li, Yang Shi.   

Abstract

Constitutive ablation of the Yin Yang 1 (YY1) transcription factor in mice results in peri-implantation lethality. In this study, we used homologous recombination to generate knockout mice carrying yy1 alleles expressing various amounts of YY1. Phenotypic analysis of yy1 mutant embryos expressing approximately 75%, approximately 50%, and approximately 25% of the normal complement of YY1 identified a dosage-dependent requirement for YY1 during late embryogenesis. Indeed, reduction of YY1 levels impairs embryonic growth and viability in a dose-dependent manner. Analysis of the corresponding mouse embryonic fibroblast cells also revealed a tight correlation between YY1 dosage and cell proliferation, with a complete ablation of YY1 inducing cytokinesis failure and cell cycle arrest. Consistently, RNA interference-mediated inhibition of YY1 in HeLa cells prevents cytokinesis, causes proliferative arrest, and increases cellular sensitivity to various apoptotic agents. Genome-wide expression profiling identified a plethora of YY1 target genes that have been implicated in cell growth, proliferation, cytokinesis, apoptosis, development, and differentiation, suggesting that YY1 coordinates multiple essential biological processes through a complex transcriptional network. These data not only shed new light on the molecular basis for YY1 developmental roles and cellular functions, but also provide insight into the general mechanisms controlling eukaryotic cell proliferation, apoptosis, and differentiation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16611997      PMCID: PMC1447422          DOI: 10.1128/MCB.26.9.3565-3581.2006

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  82 in total

1.  Global transcriptional program of p53 target genes during the process of apoptosis and cell cycle progression.

Authors:  Asra Mirza; Qun Wu; Luquan Wang; Terri McClanahan; W Robert Bishop; Ferdous Gheyas; Wei Ding; Beth Hutchins; Tish Hockenberry; Paul Kirschmeier; Jonathan R Greene; Suxing Liu
Journal:  Oncogene       Date:  2003-06-05       Impact factor: 9.867

2.  Interaction of YY1 with E2Fs, mediated by RYBP, provides a mechanism for specificity of E2F function.

Authors:  Susanne Schlisio; Terri Halperin; Miguel Vidal; Joseph R Nevins
Journal:  EMBO J       Date:  2002-11-01       Impact factor: 11.598

3.  Transcription factor YY1 functions as a PcG protein in vivo.

Authors:  Lakshmi Atchison; Ayesha Ghias; Frank Wilkinson; Nancy Bonini; Michael L Atchison
Journal:  EMBO J       Date:  2003-03-17       Impact factor: 11.598

4.  Targeted recruitment of a histone H4-specific methyltransferase by the transcription factor YY1.

Authors:  Natalie Rezai-Zadeh; Xiaohong Zhang; Fares Namour; Gyorgy Fejer; Yu-Der Wen; Ya-Li Yao; Ildiko Gyory; Kenneth Wright; Edward Seto
Journal:  Genes Dev       Date:  2003-04-15       Impact factor: 11.361

5.  Essential function of p300 acetyltransferase activity in heart, lung and small intestine formation.

Authors:  Noriko Shikama; Werner Lutz; Ralph Kretzschmar; Nadine Sauter; Jeanne-Françoise Roth; Silvia Marino; Jonas Wittwer; Alexander Scheidweiler; Richard Eckner
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

Review 6.  Isolation of p53-target genes and their functional analysis.

Authors:  Yusuke Nakamura
Journal:  Cancer Sci       Date:  2004-01       Impact factor: 6.716

7.  Induction of p53-regulated genes in lung cancer cells: implications of the mechanism for adenoviral p53-mediated apoptosis.

Authors:  Jian Gu; Lidong Zhang; Stephen G Swisher; Jinsong Liu; Jack A Roth; Bingliang Fang
Journal:  Oncogene       Date:  2004-02-12       Impact factor: 9.867

8.  YY1 binding to a subset of p53 DNA-target sites regulates p53-dependent transcription.

Authors:  Tatiana Yakovleva; Larissa Kolesnikova; Vladana Vukojević; Irina Gileva; Koichi Tan-No; Matthias Austen; Bernhard Lüscher; Tomas J Ekström; Lars Terenius; Georgy Bakalkin
Journal:  Biochem Biophys Res Commun       Date:  2004-05-28       Impact factor: 3.575

9.  Yin Yang 1, a vertebrate polycomb group gene, regulates antero-posterior neural patterning.

Authors:  Hye-Joo Kwon; Hae-Moon Chung
Journal:  Biochem Biophys Res Commun       Date:  2003-07-11       Impact factor: 3.575

10.  The gene encoding the transcriptional regulator Yin Yang 1 (YY1) is a myeloid transforming gene interfering with neutrophilic differentiation.

Authors:  Stefan J Erkeland; Marijke Valkhof; Claudia Heijmans-Antonissen; Ruud Delwel; Peter J M Valk; Mirjam H A Hermans; Ivo P Touw
Journal:  Blood       Date:  2002-09-12       Impact factor: 22.113

View more
  103 in total

1.  Yin-Yang1 is required for epithelial-to-mesenchymal transition and regulation of Nodal signaling during mammalian gastrulation.

Authors:  Mary C Trask; Kimberly D Tremblay; Jesse Mager
Journal:  Dev Biol       Date:  2012-06-02       Impact factor: 3.582

2.  Systematic proteome analysis identifies transcription factor YY1 as a direct target of miR-34a.

Authors:  Qing-Rong Chen; Li-Rong Yu; Patricia Tsang; Jun S Wei; Young K Song; Adam Cheuk; Joon-Yong Chung; Stephen M Hewitt; Timothy D Veenstra; Javed Khan
Journal:  J Proteome Res       Date:  2010-12-23       Impact factor: 4.466

3.  A YY1-INO80 complex regulates genomic stability through homologous recombination-based repair.

Authors:  Su Wu; Yujiang Shi; Peter Mulligan; Frédérique Gay; Joseph Landry; Huifei Liu; Ju Lu; Hank H Qi; Weijia Wang; Jac A Nickoloff; Carl Wu; Yang Shi
Journal:  Nat Struct Mol Biol       Date:  2007-11-18       Impact factor: 15.369

4.  The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma.

Authors:  Rabea Wagener; Julian Seufert; Francesco Raimondi; Susanne Bens; Kortine Kleinheinz; Inga Nagel; Janine Altmüller; Holger Thiele; Daniel Hübschmann; Christian W Kohler; Peter Nürnberg; Rex Au-Yeung; Birgit Burkhardt; Heike Horn; Lorenzo Leoncini; Elaine S Jaffe; German Ott; Grzegorz Rymkiewicz; Matthias Schlesner; Robert B Russell; Wolfram Klapper; Reiner Siebert
Journal:  Blood       Date:  2018-12-19       Impact factor: 22.113

5.  YY1's longer DNA-binding motifs.

Authors:  Jeong do Kim; Joomyeong Kim
Journal:  Genomics       Date:  2008-11-08       Impact factor: 5.736

6.  Decreased genetic dosage of hepatic Yin Yang 1 causes diabetic-like symptoms.

Authors:  Francisco Verdeguer; Sharon M Blättler; John T Cunningham; Jessica A Hall; Helen Chim; Pere Puigserver
Journal:  Mol Endocrinol       Date:  2014-01-27

7.  The role of YY1 in reduced HP1alpha gene expression in invasive human breast cancer cells.

Authors:  Jason G Lieberthal; Marissa Kaminsky; Christopher N Parkhurst; Naoko Tanese
Journal:  Breast Cancer Res       Date:  2009-06-30       Impact factor: 6.466

8.  Genome-wide analysis of YY2 versus YY1 target genes.

Authors:  Li Chen; Toshi Shioda; Kathryn R Coser; Mary C Lynch; Chuanwei Yang; Emmett V Schmidt
Journal:  Nucleic Acids Res       Date:  2010-03-09       Impact factor: 16.971

9.  PI 3 kinase related kinases-independent proteolysis of BRCA1 regulates Rad51 recruitment during genotoxic stress in human cells.

Authors:  Ian Hammond-Martel; Helen Pak; Helen Yu; Raphael Rouget; Andrew A Horwitz; Jeffrey D Parvin; Elliot A Drobetsky; El Bachir Affar
Journal:  PLoS One       Date:  2010-11-17       Impact factor: 3.240

10.  Developmental expression profile of the YY2 gene in mice.

Authors:  David Drews; Martin Klar; Christof Dame; Anja U Bräuer
Journal:  BMC Dev Biol       Date:  2009-07-28       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.